Long Grove Pharmaceuticals Cyclophosphamide for Injection
Cyclophosphamide for Injection contains stainless steel particulate matter that can cause serious adverse events, including death.
High risk
There is a reasonable chance that taking it could cause serious health problems or death.
FDA Class I recall · How risk is rated
What happened
Sunny Pharmtech Inc., of Taoyuan City, Taiwan, is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, in 1 gram/vial and 2 gram/vial strengths, to the user level due to the presence of particulate matter identified as steel. The recall was initiated July 17, 2026, and announced by the company on July 24, 2026. The products were distributed nationwide in the USA.
The recalled vials are manufactured for Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018, and manufactured in Taiwan. As of the announcement, no adverse events or injuries associated with this particulate matter had been reported.
Summary by Recall Canary from the FDA notice.
What to do
If a code on your package matches:
- Consumers with questions regarding this recall may contact Sunny Pharmtech, Inc. at 886-3-4809168, Ext.
- Contact your physician or healthcare provider if you have experienced any problem that may be related to taking or using this drug product and do not stop or change prescribed treatment without consulting a healthcare professional.
- Pharmacies, hospitals, and other healthcare providers that have the recalled product should immediately stop use and dispensing, and quarantine all affected product inventory, and follow the instructions in the recall notification for arranging return of the affected lots to Cardinal Health.
- 7205 or ra@
sunnypharmtech.com, Monday through Friday from 9AM to 5PM GMT+8.
Is yours affected?
Match your product and all the details in one listed combination.
Cyclophosphamide for Injection, USP
- NDC
- 81298-8112-1
- Lot code
- C23019V1
- Best-by
- Oct-2026
- Dosage form / package
- 1 g/vial, 50mL vial
- NDC
- 81298-8112-1
- Lot code
- C24015V1
- Best-by
- Apr-2027
- Dosage form / package
- 1 g/vial, 50mL vial
- NDC
- 81298-8114-1
- Lot code
- V24010V1
- Best-by
- Mar-2027
- Dosage form / package
- 2 g/vial, 100 mL vial
Details
- Company began the recall
- Sold in
USA Nationwide
- Event ID
- 99437
- Recall numbers
- D-0743-2026 to D-0744-2026
- Company
- Sunny Pharmtech Inc.Taoyuan City, Taiwan
- Hazard
- Foreign material
Company began the recall
Announced by the company · Listed on Recall Canary
Added to FDA's Enforcement Report
Classified by FDA
In FDA's weekly enforcement report
Summary updated
